Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Etf Name | Etf Symbol | Market | Stock Type |
|---|---|---|---|
| Virtus LifeSci Biotech Clinical Trials ETF | BBC | AMEX | Exchange Traded Fund |
| Price Change | Price Change % | Etf Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 26.2522 | 05:59:34 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 26.2522 |
| Trades | Etfs Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 16.88 - 31.99 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | 26.2522 | USD |
Virtus LifeSci Biotech Clinical Trials ETF Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 11.81M | 450.00k | - | 132k | -4.06M | -9.03 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Virtus LifeSci Biotech C...
Real-Time news about Virtus LifeSci Biotech Clinical Trials ETF (American Stock Exchange): 0 recent articles
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
BBC Historical
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 25.28 | 26.46 | 24.512 | 25.60 | 1,225 | 0.9722 | 3.85% |
| 1 Month | 28.35 | 28.35 | 24.512 | 27.07 | 2,908 | -2.10 | -7.40% |
| 3 Months | 25.87 | 31.99 | 24.512 | 28.69 | 4,269 | 0.3822 | 1.48% |
| 6 Months | 16.91 | 31.99 | 16.91 | 26.09 | 3,269 | 9.34 | 55.25% |
| 1 Year | 23.22 | 31.99 | 16.88 | 25.19 | 2,269 | 3.03 | 13.06% |
| 3 Years | 50.78 | 52.18 | 16.88 | 32.11 | 3,361 | -24.53 | -48.30% |
| 5 Years | 28.30 | 62.60 | 16.88 | 37.69 | 9,138 | -2.05 | -7.24% |
| The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering (lead drug) that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval. |
